According to Zydus Lifesciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.34503. At the end of 2023 the company had a P/S ratio of 3.28.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.28 | 25.72% |
2022 | 2.61 | -21.07% |
2021 | 3.31 | -3.68% |
2020 | 3.43 | 85.49% |
2019 | 1.85 | -33.02% |
2018 | 2.76 | -31.13% |
2017 | 4.01 | 1.7% |
2016 | 3.94 | 14.88% |
2015 | 3.43 | -9.57% |
2014 | 3.80 | 61.01% |
2013 | 2.36 | -23.48% |
2012 | 3.08 |